# Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder

> **NCT00916396** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Hypoactive Sexual Desire Disorder

## Interventions

- **DRUG:** Dehydroepiandrosterone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00916396
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-06
- **Primary completion:** 2011-01
- **Final completion:** 2011-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916396, "Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT00916396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*